Neuregulin-1 prevents death from a normally lethal respiratory viral infection

Syed-Rehan A Hussain1,2, Michelle Rohlfing1,2, Jennifer Santoro1,2

  • 1Division of Allergy and Immunology, Nationwide Children's Hospital - The Ohio State University College of Medicine, Columbus, Ohio, United States of America.

Plos Pathogens
|April 23, 2025
PubMed

Insights

Neuregulin-1 (NRG1) protects against lethal respiratory viral infections by stabilizing lung epithelial integrity and inhibiting cell death. This discovery offers a potential therapeutic target for severe respiratory illnesses like RSV and influenza.

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • Respiratory infections caused by RNA viruses like respiratory syncytial virus (RSV) and influenza result in substantial illness and death.
  • Atopic mice, sensitized with house dust mite, exhibited increased survival against a typically lethal Sendai virus (SeV) infection.

Purpose of the Study:

  • To investigate the protective role of neuregulin-1 (NRG1) in respiratory viral infections.
  • To determine the mechanisms by which NRG1 confers protection against viral-induced lung injury and mortality.

Main Methods:

  • Utilized a Sendai virus (SeV) mouse model and influenza A virus (IAV) infection model.
  • Administered NRG1 to atopic and naive mice, assessing survival rates and physiological parameters.
  • Conducted in vitro studies on mouse lung epithelial cells and human bronchial epithelial cells infected with SeV or RSV, respectively, to examine necroptosis and epithelial barrier function.

Main Results:

  • NRG1 was found to be elevated in atopic mice infected with SeV.
  • NRG1 administration protected mice from lethal SeV and IAV infections, reducing alveolar epithelial permeability and inhibiting necroptosis (indicated by reduced MLKL phosphorylation).
  • In vitro, NRG1 inhibited SeV-induced necroptosis in mouse lung cells and reduced RSV-induced fluid leak and necroptosis gene expression (RIPK3, MLKL) in human bronchial cells, promoting epithelial integrity.

Conclusions:

  • Neuregulin-1 (NRG1) plays a critical role in mitigating respiratory viral infections.
  • NRG1 functions by reducing alveolar leak, inhibiting epithelial necroptosis, and promoting airway epithelial homeostasis.
  • These protective effects of NRG1 are associated with significantly reduced mortality following respiratory viral insults, suggesting its therapeutic potential.